Literature DB >> 10816710

Assessing new health technologies: lessons to be learned from drugs.

D A Henry1, S R Hill.   

Abstract

Balancing the interests of producers, consumers and purchasers (governments) increases the complexity of evidence-based evaluation of non-drug health technologies.

Mesh:

Substances:

Year:  1999        PMID: 10816710     DOI: 10.5694/j.1326-5377.1999.tb123795.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  1 in total

1.  Assessing the impact of the Australia-United States Free Trade Agreement on Australian and global medicines policy.

Authors:  Thomas Faunce; Evan Doran; David Henry; Peter Drahos; Andrew Searles; Brita Pekarsky; Warwick Neville
Journal:  Global Health       Date:  2005-10-06       Impact factor: 4.185

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.